Form 4: ClearPoint Neuro Director Linda M. Liau Acquires Shares in Lieu of Fees

Director Linda M. Liau acquired 436 shares of ClearPoint Neuro, Inc. common stock on April 1, 2024, as payment for fees under the company's Non-Employee Director Compensation Plan.

Summary

• On April 1, 2024, Linda M. Liau, a director of ClearPoint Neuro, Inc., acquired 436 shares of common stock.
• The shares were issued as payment for fees owed to Liau under the company's Non-Employee Director Compensation Plan.
• The shares were issued at a price of $6.80, which was the closing price of ClearPoint Neuro's common stock on March 28, 2024.
• Following the transaction, Liau directly owns 13,131 shares of ClearPoint Neuro, Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction (director receiving stock compensation) which is generally viewed as a positive sign of alignment with shareholder interests, but it's not a major event.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.
• Using stock to pay director fees conserves the company's cash resources.

Industry Context

Directors receiving stock in lieu of cash compensation is a common practice, especially for smaller companies, to preserve cash and align director interests with shareholders.

Comparison to Industry Standards

• Stock compensation for board members is a common practice across the industry, particularly in growth-oriented companies.
• Companies like Intuitive Surgical and Medtronic also utilize stock options and grants as part of their director compensation packages.
• The amount of stock granted to Linda M. Liau is relatively small, suggesting it is a portion of her overall compensation.

Stakeholder Impact

• Shareholders may view the transaction positively as it aligns the director's interests with the company's performance.
• The company benefits from conserving cash by issuing stock instead of cash compensation.

Key Dates